Peiying Yang

8.1k total citations · 1 hit paper
163 papers, 5.5k citations indexed

About

Peiying Yang is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Peiying Yang has authored 163 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 56 papers in Pharmacology and 29 papers in Cancer Research. Recurrent topics in Peiying Yang's work include Inflammatory mediators and NSAID effects (51 papers), Estrogen and related hormone effects (20 papers) and Eicosanoids and Hypertension Pharmacology (17 papers). Peiying Yang is often cited by papers focused on Inflammatory mediators and NSAID effects (51 papers), Estrogen and related hormone effects (20 papers) and Eicosanoids and Hypertension Pharmacology (17 papers). Peiying Yang collaborates with scholars based in United States, China and Australia. Peiying Yang's co-authors include Robert A. Newman, Susan M. Fischer, Lorenzo Cohen, Carrie Cartwright, Diana Chan, Edward Felix, Timothy Madden, Imad Shureiqi, David G. Menter and Scott M. Lippman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peiying Yang

161 papers receiving 5.3k citations

Hit Papers

KAT2A coupled with the α-KGDH complex acts as a histone H... 2017 2026 2020 2023 2017 100 200 300

Peers

Peiying Yang
Emanuela Ricciotti United States
Peiying Yang
Citations per year, relative to Peiying Yang Peiying Yang (= 1×) peers Emanuela Ricciotti

Countries citing papers authored by Peiying Yang

Since Specialization
Citations

This map shows the geographic impact of Peiying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiying Yang more than expected).

Fields of papers citing papers by Peiying Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiying Yang. The network helps show where Peiying Yang may publish in the future.

Co-authorship network of co-authors of Peiying Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Peiying Yang. A scholar is included among the top collaborators of Peiying Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiying Yang. Peiying Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Lorenzo, Suzanne C. Danhauer, Emily V. Dressler, et al.. (2024). Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer. JAMA Network Open. 7(5). e2410421–e2410421. 8 indexed citations
2.
Fields, Chris, Lorenzo Cohen, Sharmistha Chakraborty, et al.. (2024). Search for Entanglement between Spatially Separated Living Systems: Experiment Design, Results, and Lessons Learned. SHILAP Revista de lepidopterología. 4(2). 168–181. 1 indexed citations
3.
Gouda, Mohamed A., Aung Naing, Ecaterina E. Dumbrava, et al.. (2024). A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3152–3152. 1 indexed citations
4.
Wei, Daoyan, et al.. (2023). Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 22(6). 693–705. 5 indexed citations
5.
Wei, Daoyan, Liang Wang, Yi Liu, et al.. (2023). Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Digestive Diseases and Sciences. 68(7). 3043–3058. 6 indexed citations
6.
Bowers, Laura W., Nadia A. Lanman, Caroline Himbert, et al.. (2022). Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer. Cancer Prevention Research. 15(8). 481–495. 7 indexed citations
7.
Yin, Taijun, Bo Wei, Peiying Yang, et al.. (2021). Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer. Journal of Natural Products. 84(9). 2486–2495. 8 indexed citations
8.
Cata, Juan P., Michael J. Lacagnina, Ayşegül Görür, et al.. (2021). A rat model to investigate quality of recovery after abdominal surgery. PAIN Reports. 6(2). e943–e943. 4 indexed citations
9.
Shelmadine, Brian, et al.. (2017). A Pilot Study to Examine the Effects of an Anti-inflammatory Supplement on Eicosanoid Derivatives in Patients with Chronic Kidney Disease. The Journal of Alternative and Complementary Medicine. 23(8). 632–638. 20 indexed citations
10.
Fan, Yang-Yi, Evelyn Callaway, Jennifer M. Monk, et al.. (2016). A New Model to Study the Role of Arachidonic Acid in Colon Cancer Pathophysiology. Cancer Prevention Research. 9(9). 750–757. 8 indexed citations
11.
Jiang, Yan, Yong Pan, Lin Tan, et al.. (2016). A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway. Cancer Research. 76(1). 24–29. 70 indexed citations
12.
Ford, Nikki A., Emily L. Rossi, Peiying Yang, et al.. (2015). Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer. Cancer Prevention Research. 8(9). 796–806. 18 indexed citations
13.
Shureiqi, Imad, Dongning Chen, R. Sue Day, et al.. (2010). Profiling Lipoxygenase Metabolism in Specific Steps of Colorectal Tumorigenesis. Cancer Prevention Research. 3(7). 829–838. 46 indexed citations
14.
Lee, Chung‐Wei, Barry Rickman, Arlin B. Rogers, et al.. (2009). Combination of Sulindac and Antimicrobial Eradication of Helicobacter pylori Prevents Progression of Gastric Cancer in Hypergastrinemic INS-GAS Mice. Cancer Research. 69(20). 8166–8174. 50 indexed citations
15.
Yang, Peiying, David G. Menter, Carrie Cartwright, et al.. (2009). Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets. Molecular Cancer Therapeutics. 8(8). 2319–2328. 70 indexed citations
16.
Hughes, Duncan, Peiying Yang, Robert A. Newman, et al.. (2008). NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer. Cancer Prevention Research. 1(4). 241–249. 39 indexed citations
17.
Jia, Qian, Joanne R. Lupton, Roger Smith, et al.. (2008). Reduced Colitis-Associated Colon Cancer in Fat-1 ( n -3 Fatty Acid Desaturase) Transgenic Mice. Cancer Research. 68(10). 3985–3991. 114 indexed citations
18.
Schroeder, Claudia P., Peiying Yang, Robert A. Newman, & Reuben Lotan. (2007). Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines.. PubMed. 6(3). 183–92. 20 indexed citations
19.
Yang, Peiying, Diana Chan, Carrie Cartwright, et al.. (2006). The dual PPARα/γ ligand TZD18 inhibits cell growth and induces apoptosis in human Bcr-Abl positive CML cell lines >in vitro. Cancer Research. 66. 906–906. 1 indexed citations
20.
Yang, Peiying, Peter D. Collin, Timothy Madden, et al.. (2003). Inhibition of proliferation of PC3 cells by the branched‐chain fatty acid, 12‐methyltetradecanoic acid, is associated with inhibition of 5‐lipoxygenase. The Prostate. 55(4). 281–291. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026